Showing results (21-30 of 307) with videos related to
Sort By:
Pageof 31
Cardiology Clinics|May 1, 1983
Clinical electrophysiology of ventricular tachycardiaE N Prystowsky, J J Heger, E A Lloyd, et al.The American Journal of Cardiology|January 1, 1983
Cellular electrophysiologic abnormalities of diseased human ventricular myocardiumR F Gilmour, J J Heger, E N Prystowsky, et al.Pacing and Clinical Electrophysiology : PACE|May 1, 1984
Future directions: electrical therapy for cardiac tachyarrhythmiasD P Zipes, E N Prystowsky, W M Miles, et al.The American Journal of Cardiology|November 14, 1984
Propafenone treatment of recurrent ventricular tachycardia: comparison of continuous electrocardiographic recording and electrophysiologic study in predicting drug efficacyJ J Heger, J Hubbard, D P Zipes, et al.American Heart Journal|December 1, 1980
Studies with aprindineD P Zipes, V Elharrar, R F Gilmour, et al.Circulation|September 1, 1986
The preexcitation index: an aid in determining the mechanism of supraventricular tachycardia and localizing accessory pathwaysW M Miles, R Yee, G J Klein, et al.Journal of the American College of Cardiology|March 1, 1984
Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmiasK F Browne, E N Prystowsky, D P Zipes, et al.The American Journal of Cardiology|January 1, 1986
Survivors of cardiac arrest: prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoringB T Skale, W M Miles, J J Heger, et al.The American Journal of Cardiology|July 1, 1983
Syncope and ventricular tachycardia in patients with ventricular preexcitationE A Lloyd, R N Hauer, D P Zipes, et al.The New England Journal of Medicine|August 4, 1988
Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapyJ D Minardo, J J Heger, W M Miles, et al.Pageof 31